Upload

Loading icon Loading...

This video is unavailable.

AHA: Statins in the Water? HS-CRP as a Therapeutic Target?

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like MedPageToday's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike MedPageToday's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add MedPageToday's video to your playlist.

Uploaded on Nov 17, 2008

http://www.medpagetoday.com

NEW ORLEANS, Nov. 9 -- Results of the JUPITER trial are likely to expand use of statins and highly-sensitive CRP measurement, but how much and how soon remain to be seen, according to participants in an exclusive MedPage Today roundtable discussion.
Robert Bonow, M.D., of Northwestern University in Chicago and a former president of the American Heart Association, Gordon F. Tomaselli, M.D., of Johns Hopkins University in Baltimore and chairman of the association's program committee, and Anthony De Maria, M.D., of the University of California at San Diego and editor-in-chief of the Journal of the American College of Cardiology, sat down with Peggy Peck, MedPage Today executive editor, to look at the clinical implications of the landmark trial.

One thing all three agreed on: The results are likely to bring about changes in clinical guidelines.

  • Category

  • License

    Standard YouTube License

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
Sign in to add this to Watch Later

Add to